Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
1.330
+0.010 (0.76%)
Nov 26, 2025, 4:00 PM EST - Market closed
Humacyte Market Cap
Humacyte has a market cap or net worth of $249.07 million as of November 26, 2025. Its market cap has decreased by -64.15% in one year.
Market Cap
249.07M
Enterprise Value
280.55M
1-Year Change
-64.15%
Ranking
Category
Stock Price
$1.33
Market Cap Chart
Since December 1, 2020, Humacyte's market cap has increased from $124.31M to $249.07M, an increase of 100.37%. That is a compound annual growth rate of 14.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 26, 2025 | 249.07M | -61.67% |
| Dec 31, 2024 | 649.78M | 120.90% |
| Dec 29, 2023 | 294.15M | 35.19% |
| Dec 30, 2022 | 217.58M | -70.86% |
| Dec 31, 2021 | 746.77M | 471.21% |
| Dec 31, 2020 | 130.74M | 5.17% |
| Dec 1, 2020 | 124.31M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 988.81B |
| Johnson & Johnson | 500.07B |
| AbbVie | 402.36B |
| UnitedHealth Group | 298.66B |
| AstraZeneca | 290.32B |
| Merck & Co. | 259.69B |
| Novartis AG | 251.09B |
| Abbott Laboratories | 223.51B |